Announcement
Test News
Tested news item
Document attached
Newsroom
News and safety alerts
868 items
Announcements, product safety communications and regulatory updates.
Announcement QUEST
New Login Method for QUEST3+ System – MyTrustID
Pengumuman: Kaedah Log Masuk Baharu Sistem QUEST3+ – MyTrustID Dimaklumkan bahawa satu kaedah log masuk baharu bagi Sistem QUEST3+, iaitu MyTrustID, akan dilaksanakan mulai 8 Julai 2026 (Rabu), jam…
Document attached
Safety Alerts
Lamotrigine: Risk of Photosensitivity Reactions
DISCLAIMER: This publication is intended for healthcare professionals. The information provided aims to update on medication safety issues and should not substitute clinical judgement. While…
Document attached
Safety Alerts
Cefazolin: Risk of Kounis Syndrome
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Safety Alerts
Aciclovir (Oral/Injectable) and Valaciclovir: Risk of Acute Generalised Exanthematous Pustulosis (AGEP)
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues and not as a substitute for clinical judgement. While reasonable…
Announcement
PELAKSANAAN KAJIAN KEPUASAN PELANGGAN LUARAN PROGRAM PERKHIDMATAN FARMASI, KKM
Dengan segala hormatnya perkara di atas adalah dirujuk. 2. Sukacita dimaklumkan bahawa Program Perkhidmatan Farmasi (PPF), KKM sedang melaksanakan Kajian Kepuasan Pelanggan Luaran bermula 1 Jun 2026…
Direct healthcare professional communications (DHPC)
POLIVY® (Polatuzumab Vedotin): Identified Risk – Severe Infusion Site Extravasation Events
DISCLAIMER: This publication is intended for healthcare professionals. The information provided aims to update on medication safety issues and should not substitute clinical judgement. While…
Direct healthcare professional communications (DHPC)
COLUMVI® (Glofitamab): New Important Identified Risk of Haemophagocytic Lymphohistiocytosis
DISCLAIMER: This publication is intended for healthcare professionals. The information provided aims to update on medication safety issues and should not substitute clinical judgement. While…
Safety Alerts
Clindamycin Hydrochloride (Oral Capsules): Risk of Oesophagitis and Oesophageal Ulcer
DISCLAIMER: This publication is intended for healthcare professionals. The information provided aims to update on medication safety issues and should not substitute clinical judgment. While…
Document attached
Safety Alerts
Mesalazine: Risk of Idiopathic Intracranial Hypertension (IIH)
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Safety Alerts
Moxifloxacin: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Fixed-Drug Eruption (FDE), and Photosensitivity Associated with Systemic Use
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Safety Alerts
Sunitinib: Risk of Hyperammonaemic Encephalopathy
DISCLAIMER: This publication is intended for healthcare professionals. The information provided aims to update on medication safety issues and should not substitute clinical judgement. While…
Announcement
Official Launch of the NPRA GCP, GLP, BE & EC Inspection Dashboard
The National Pharmaceutical Regulatory Agency (NPRA) is pleased to announce that the NPRA GCP, GLP, BE and EC Inspection Dashboard is now officially live on the NPRA website. The development of this…
Announcement QUEST
Update Of 'Borang Permohonan Sijil Indikasi / Sijil Deklarasi Bagi Produk Berdaftar Dengan Pihak Berkuasa Kawalan Dadah'
UPDATE OF 'BORANG PERMOHONAN SIJIL INDIKASI / SIJIL DEKLARASI BAGI PRODUK BERDAFTAR DENGAN PIHAK BERKUASA KAWALAN DADAH'Sir/ Madam,Please be informed that the application form for the Certificate of…
Announcement
Update on Analytical Testing and Labelling Declaration Requirements for Products Containing Animal-Derived Materials
The Drug Control Authority (DCA) has approved updated policies regarding animal-derived materials for all product categories via Circular NPRA.600-1/9/12 (31). This update introduces a risk-based…
Document attached
Press Release
Kenyataan Media KKM 2 April 2026- Makluman Kosmetik yang Dikesan Mengandungi Racun Berjadual
Document attached
Announcement
Latihan Sangkutan di NPRA bagi Latihan Liberalisasi Ahli Farmasi Provisional (PRP) di bawah Bahagian Lembaga Farmasi Malaysia (BLFM): Industri Farmaseutikal Mengilang / Industri Farmaseutikal Tidak Mengilang (Sesi 01/2026)
Pengumuman Latihan Sangkutan di NPRA bagi Latihan Liberalisasi Ahli Farmasi Provisional (PRP) di bawah Bahagian Lembaga Farmasi Malaysia (BLFM): Industri Farmaseutikal Mengilang / Industri…
Direct healthcare professional communications (DHPC)
PLAQUENIL® (Hydroxychloroquine): Potential Risk of Major Congenital Malformations and New Risks of Phospholipidosis and Aggravation of Myasthenia Gravis Symptoms
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Direct healthcare professional communications (DHPC)
CELLCEPT® (Mycophenolate mofetil): New Important Identified Risk – Anaphylactic Reaction
DISCLAIMER: This publication is intended for healthcare professionals. The information provided aims to update on medication safety issues and should not substitute clinical judgment. While…
Safety Alerts
Denosumab (Prolia®) and Biosimilars: Multi Vertebral Fractures (MVF) after Discontinuation of Denosumab – Strengthened Warnings
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Press Release
Kenyataan Media KKM 9 Februari 2026- Makluman Kosmetik yang Dikesan Mengandungi Racun Berjadual
Document attached
Announcement
OFFICIAL ANNOUNCEMENT: NATIONAL REGULATORY CONFERENCE 2026
The National Pharmaceutical Regulatory Agency (NPRA) and the Malaysian Pharmacists Society (MPS) are proud to present the National Regulatory Conference (NRC) 2026. This premier platform brings…
Safety Alerts
Palbociclib: Risk of Venous Thromboembolism
DISCLAIMER: This publication is intended for healthcare professionals. The information provided aims to update on medication safety issues and should not substitute clinical judgment. While…
Safety Alerts
Vitamin B6 (Pyridoxine): Risk of Peripheral Neuropathy
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Safety Alerts
Garcinia Cambogia and Hydroxycitric Acid: Risk of Hepatotoxicity
DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…
Document unavailable